Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients: A Nationwide Data Survey and Propensity Analysis

Long-term benefit of using a renin–angiotensin–aldosterone system blocker such as an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker (ARB) for patients already receiving dialysis remains undetermined. The aim of this study is to assess the efficacy and safety of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore)
Hauptverfasser: Wu, Cho-Kai, Yang, Yao-Hsu, Juang, Jyh-Ming Jimmy, Wang, Yi-Chih, Tsai, Chia-Ti, Lai, Ling-Ping, Hwang, Juey-Jen, Chiang, Fu-Tien, Chen, Pau-Chung, Lin, Jiunn-Lee, Lin, Lian-Yu
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wolters Kluwer Health 2015
Schlagworte:
3400
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602640/
https://ncbi.nlm.nih.gov/pubmed/25621694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000424
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge